Useful resources |
Interleukin 2 receptor antagonists for kidney transplant recipients (Cochrane Review) ABSTRACT Background: Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily, with 38% of new kidney transplant recipients in the United States, . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |